Health Condition 1: B359- Dermatophytosis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex aged between 18- 65 years 2. Subjects with KOH positive/microscopically confirmed 3. Clinical signs and symptoms suggestive of fungal infection viz. annular / arcuate polycyclic lesion with clear centre and an active margin with papulo-vesicles & scaling; erythema, itching, burning.
Exclusion criteria
Exclusion criteria: 1. Patients of either sex 65 years 2. Superficial skin disease like Eczema/psoriasis/scabies 3. Superadded infections 4. Lactating and pregnant women 5. Subjects with Tinea capitis (tinea of scalp), Onychomycosis (tinea of nails) and Tinea barbae (tinea of beard) 6. Subjects who are concomitantly using any anti-fungal product in any form 7. Known cases of allergy to any ingredients of the study drug 8. Subjects with systemic diseases requiring long-term treatment 9. Subjects not willing to undergo the specified washout periods (for topical preparations not less than 2 weeks & for systemic medicines 4 weeks)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in sign and symptoms of Qooba (Dermatophytosis)Timepoint: 05 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment | — |
Countries
India
Contacts
Central Council for Research in Unani Medicine (CCRUM)